Potential inflammatory targets in the integrative health care of patients with sickle cell disease

被引:0
|
作者
Khan, Shahida A. [1 ,2 ]
Halawani, Saeed H. [3 ]
Al Zughaibi, Torki [1 ,2 ]
Khan, Sarah A. [1 ]
机构
[1] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Sci, Jeddah 22252, Saudi Arabia
[3] Umm Al Qura Univ, Fac Med, Dept Hematol & Immunol, Mecca 21955, Saudi Arabia
关键词
inflammation; marker; sickle cell disease; C-REACTIVE PROTEIN; VASOOCCLUSIVE CRISIS; HOMOCYSTEINE LEVEL; CHILDREN; ADOLESCENTS;
D O I
10.3892/etm.2023.12184
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. As disease severity increases with age, the present study aimed to assess if age is also correlated with a definite pattern of progression of the two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and total homocysteine (tHCY). The findings of the present study could lead to an improved understanding of the threshold levels of these inflammatory markers and timely interventions to delay complications. In an observational study, levels of hsCRP and tHCY were analyzed in 70 patients (35 male and 35 female patients) with SCD aged between 5 and 16 years. hsCRP levels were in the high-risk range in 64.29% (n=45) of all male and female patients. A sex-wise distribution showed that, of the 35 male patients, 74.28% (n=26) were in the high-risk range, and of the 35 female patients, 54.28% (n=19) were in the high-risk range. An age-wise distribution showed that of the 41 patients in the 5-10-years age group, 70.73% (n=29), were in the high-risk range. In comparison, of the 29 patients in the 11-16-years age group, 55.17% (n=16) were in the high-risk range. tHCY levels were observed to be in the normal range in 98.57% (n=69) of all children, as compared with 1.43% (n=1) in the high-risk range. Furthermore, a sex-wise distribution showed that female patients in the high-risk group of hsCRP had higher concentrations of tHCY as compared with the male patients in that risk group. An age-wise distribution of hsCRP concentration also showed that the risk of CVD in patients in the 11-16-years age group was higher with increased concentrations of tHCY. A weak negative correlation was observed between age and hsCRP concentrations (r-value=-0.280; P=0.026) and a weak positive correlation was detected between tHCY and age (r-value=0.259; P=0.036). In conclusion, the results of the present study indicated that higher levels of hsCRP could be a useful marker in children with SCD, and levels of tHCY may be an adjunct marker as the disease progresses with age.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Reducing Health Care Disparities in Sickle Cell Disease: A Review
    Lee, LaTasha
    Smith-Whitley, Kim
    Banks, Sonja
    Puckrein, Gary
    PUBLIC HEALTH REPORTS, 2019, 134 (06) : 599 - 607
  • [2] An Integrative Review of the Prevalence of Depression among Pediatric Patients with Sickle Cell Disease
    Moody, Kendall L.
    Mercer, Kimberley
    Glass, Mitzi
    SOCIAL WORK IN PUBLIC HEALTH, 2019, 34 (04) : 343 - 352
  • [3] Transition from paediatric to adult care for patients with sickle cell disease
    de Montalembert, Mariane
    Guitton, Corinne
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 630 - 635
  • [4] Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country
    Thielen, Frederick W.
    Houwing, Maite E.
    Cnossen, Marjon H.
    al Hadithy-Irgiztseva, Ilona A.
    Hazelzet, Jan A.
    Groot, Carin A. Uyl-de
    de Pagter, Anne P. J.
    Blommestein, Hedwig M.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [5] Managing patients with sickle cell disease in primary care
    Hehre, Robert J.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (10): : 21 - 28
  • [6] Inflammatory potential of neutrophils detected in sickle cell disease
    Lum, AFH
    Wun, T
    Staunton, D
    Simon, SI
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (02) : 126 - 133
  • [7] Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation
    Toledo, Silvia L. de O.
    Guedes, Joao V. M.
    Alpoim, Patricia N.
    Rios, Danyelle R. A.
    Pinheiro, Melina de B.
    CLINICA CHIMICA ACTA, 2019, 493 : 129 - 137
  • [8] Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention
    Dutta, Dibyendu
    Aujla, Amandeep
    Knoll, Bettina M.
    Lim, Seah H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 488 - 493
  • [9] Go the Distance Reproductive Health Care for People with Sickle Cell Disease
    Pecker, Lydia H.
    Kuo, Kevin H. M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (06) : 1255 - 1270
  • [10] Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease
    de Ligt, L. A.
    Gaartman, A. E.
    Konte, K.
    Thakoerdin, S.
    Fijnvandraat, K.
    Kuijpers, T. W.
    van Bruggen, R.
    Biemond, B. J.
    Nur, E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (03) : 954 - 964